Skip to main content
Log in

Residual activity of α-galactosidase A in Fabry's disease

  • Published:
Biochemical Genetics Aims and scope Submit manuscript

Abstract

The α-galactosidase A activity from fibroblasts of five Fabry patients and five controls has been separated from α-galactosidase B through small DEAE-cellulose columns and in some experiments by treatment of the fibroblast extracts with Sepharose coupled to anti-α-galactosidase B antibodies. By these independent methods, it has been shown that there is a residual α-galactosidase A in Fabry's disease, which is immunologically similar to the α-galactosidase A from the controls. The α-galactosidase A from all of the patients and controls has the same apparent Km value for the synthetic substrate 4-methylumbelliferyl-α-galactoside. Four out of five patients have a thermostable α-galactosidase A, while the fifth has a thermolabile enzyme like that from the controls. The amount of immunologically active α-galactosidase A seems to be decreased in the patients tested.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Beutler, E., and Kuhl, W. (1972a) Biochemical and electrophoretic studies of α-galactosidase in normal man, in patients with Fabry's disease and in Equidae. Am. J. Hum. Genet. 24237.

    Google Scholar 

  • Beutler, E., and Kuhl, W. (1972b). Purification and properties of human α-galactosidases. J. Biol. Chem. 2477195.

    Google Scholar 

  • Beutler, E., and Kuhl, W. (1972c). Relationship between human α-galactosidases isozymes. Nature New Biol. 239207.

    Google Scholar 

  • Beutler, E., and Kuhl, W. (1972d). Absence of cross-reaction antigen in Fabry's disease. New Engl. J. Med. 289694.

    Google Scholar 

  • Brady, R. O., Gal, A. E., Bradley, R. M., Märtensson, E., Warshaw, A. L., and Laster, L. (1967). Enzymatic defect in Fabry's disease. New Engl. J. Med. 2761163.

    Google Scholar 

  • Brady, R. O., Tallman, J. F., Johnson, W. G., Gal, A. E., Leahy, W. R., Quirk, J. M., and De Kaban, A. S. (1973). Replacement therapy for inherited enzyme deficiency. New Engl. J. Med. 2893.

    Google Scholar 

  • Clarke, J. T. R., Knaack, J., Crawhall, J. C., and Wolfe, L. S. (1971). Ceramide trihexosidosis without skin lesions. New Engl. J. Med. 284233.

    Google Scholar 

  • Grzeschik, K. H., Grzeschik, A. M., Benoff, S., Romeo, G., Siniscalco, M., van Someren, H., Meera Khan, P., Westerveld, A., and Bottsma, D. (1972). X-linkage of α-galactosidase in man. Nature New Biol. 24048.

    Google Scholar 

  • Ho, M. W., Beutler, S., Tennant, L., and O'Brien, J. (1972). Fabry's disease: Evidence for a physically altered α-galactosidase. Am. J. Hum. Genet. 24256.

    Google Scholar 

  • Humphrey, J. H., and Porter, R. R. (1957). Reagin content of chromatographic fractions of human gamma-globulin. Lancet 1196.

    Google Scholar 

  • Kint, J. A. (1970). Fabry's disease: α-Galactosidase deficiency. Science 1671268.

    Google Scholar 

  • Kint, J. A., and Huys, A. (1972). In Zambotti, V. (ed.), Glycolipids, Glycoproteins and Mucopolysaccharides of the Nervous System, Plenum, New York, p. 273.

    Google Scholar 

  • Mapes, C. A., and Sweeley, C. C. (1973). Preparation and properties of an affinity column adsorbent for differentiation of multiple forms of α-galactosidase activity. J. Biol. Chem. 2482461.

    Google Scholar 

  • Mapes, C. A., Anderson, R. L., Sweeley, C. C., Desnick, R. J., and Krivit, W. (1970). Enzyme replacement in Fabry's disease, an inborn error of metabolism. Science 169987.

    Google Scholar 

  • Porat, J., Axen, R., and Ernback, S. (1967). Chemical coupling of proteins to agarose. Nature 2151491.

    Google Scholar 

  • Rietra, P. J. G. M., Molenar, J. L., Hamers, M. N., Tager, J. M., and Borst, P. (1974). Investigation of α-galactosidase deficiency in Fabry's disease using antibodies against the purified enzyme. Eur. J. Biochem. 4689.

    Google Scholar 

  • Romeo, G., and Migeon, B. R. (1970). Genetic inactivation of the α-galactosidase locus in carriers of Fabry's disease. Science 170180.

    Google Scholar 

  • Romeo, G., Childs, B., and Migeon, B. R. (1972). Genetic heterogeneity of α-galactosidase in Fabry's disease. FEBS Letters 27161.

    Google Scholar 

  • Romeo, G., D'Urso, M., Lee, Y. C., Wan, C. C., Li, S. C., and Li, Y. T. (1974). Cleavage of CTH and melibiose by α-galactosidase A and B of human liver. Fed. Proc. 33: abst. 430.

    Google Scholar 

  • Romeo, G., Di Matteo, G., D'Urso, M., Li, S. C., and Li, Y. T. (1975). Characterization of human α-galactosidase A and B before and after neuraminidase treatment. Biochim. Biophys. Acta 391349.

    Google Scholar 

  • Sutton, H. E., and Omenn, G. S. (1972). Fabry's disease: The search for a regulator gene mutation in man. Am. J. Hum. Genet. 24343.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romeo, G., D'Urso, M., Pisacane, A. et al. Residual activity of α-galactosidase A in Fabry's disease. Biochem Genet 13, 615–628 (1975). https://doi.org/10.1007/BF00484919

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00484919

Key words

Navigation